FDA 483 - Utah Lions Eye Bank - April 23, 2024

An FDA inspection of Utah Lions Eye Bank revealed two significant observations. The firm failed to adequately investigate environmental monitoring deviations in its tissue processing room, which showed elevated colony forming units. Additionally, the inspection found deficiencies in record-keeping for environmental monitoring and cleaning procedures, indicating a lack of detailed documentation for critical operations.